ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |
rdf:type |
rdfs:Resource |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |
rdf:type |
owl:Thing |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |
rdf:type |
ripe:IntegrityAssessmentHypothesisIntegrity assessment hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |
rdf:type |
tido:Hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |
rdf:type |
tido:PieceOfInformation |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |
prov:wasAttributedTo |
ripekg:human-reviewer/RV009 |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAA805A88D874EA69C |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAA805A88D874EA69C |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |
ripe:rationale |
I agree with INSPECT-AI. That said, I wasn’t completely sure how to interpret the “10 references with no concerns” listed here — they all point to the same paper, and none of the other papers cited within it seem to be included. Since there are no clickable links, it’s also hard to tell how they differ or how reliable the sources are. I also wondered: if there had been “10 references with some concerns,” would that make the paper 10 times more concerning if they all refer to the same source? |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |
ripe:resultOutcome |
no |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |
tido:answers |
ripekg:integrity-assessment-question/retraction-status/1.0.01.1. Does the study have an associated retraction? |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |
tido:answers |
ripekg:integrity-assessment-question/retraction-status/1.0.0retraction status |
ripekg:publication-details/RIPEAA805A88D874EA69CThe optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAA805A88D874EA69C-human-1-1 |